Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment. Journal of Korean medical science Hines, J. T., Jo, W. L., Cui, Q., Mont, M. A., Koo, K. H., Cheng, E. Y., Goodman, S. B., Ha, Y. C., Hernigou, P., Jones, L. C., Kim, S. Y., Sakai, T., Sugano, N., Yamamoto, T., Lee, M. S., Zhao, D., Drescher, W., Kim, T. Y., Lee, Y. K., Yoon, B. H., Baek, S. H., Ando, W., Kim, H. S., Park, J. W. 2021; 36 (24): e177

Abstract

Non-traumatic osteonecrosis of the femoral head (ONFH) usually affects adults younger than 50 years and frequently leads to femoral head collapse and subsequent arthritis of the hip. It is becoming more prevalent along with increasing use of corticosteroids for the adjuvant therapy of leukemia and other myelogenous diseases as well as management of organ transplantation. This review updated knowledge on the pathogenesis, classification criteria, staging system, and treatment of ONFH.

View details for DOI 10.3346/jkms.2021.36.e177

View details for PubMedID 34155839